Gene: BORCS7
Official Full Name: BLOC-1 related complex subunit 7provided by HGNC
Gene Summary: Predicted to be involved in organelle transport along microtubule; regulation of endosome size; and regulation of lysosome size. Predicted to act upstream of or within several processes, including lysosome localization; motor behavior; and response to cycloheximide. Part of BORC complex. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO30378 | BORCS7 Knockout cell line (HeLa) | Human | BORCS7 | 1:3~1:6 | Negative | Online Inquiry |
KO30379 | BORCS7 Knockout cell line (HCT 116) | Human | BORCS7 | 1:2~1:4 | Negative | Online Inquiry |
KO30380 | BORCS7 Knockout cell line (HEK293) | Human | BORCS7 | 1:3~1:6 | Negative | Online Inquiry |
KO30381 | BORCS7 Knockout cell line (A549) | Human | BORCS7 | 1:3~1:4 | Negative | Online Inquiry |
BORCS7 Gene Knockout Cell Lines are a pioneering biological tool designed to facilitate advanced research in gene function and cellular pathways. These cell lines are engineered using CRISPR-Cas9 technology to selectively disrupt the BORCS7 gene, resulting in the absence of its expression. This gene has been implicated in critical cellular processes, including lysosomal function and autophagy, making the BORCS7 Gene Knockout Cell Lines invaluable for researchers investigating the mechanisms underlying various diseases such as neurodegeneration and metabolic disorders.
The primary function of these knockout cell lines is to provide a controlled environment for studying the impact of BORCS7 gene deletion on cellular physiology. By examining how cells compensate for the loss of this gene, researchers can gain insights into compensatory mechanisms and potential therapeutic targets. The precise editing of the genome ensures that the resulting phenotypes are reproducible and reliable, a significant advantage in experimental setups.
In the context of research and clinical applications, these cell lines serve as powerful models for disease modeling, drug discovery, and basic biological research. They enable scientists to explore new pathways involved in cellular degradation and stress responses, which may lead to novel interventions in related diseases. Compared to traditional gene knockdowns, the complete knockout of BORCS7 offers a more definitive approach to understanding gene functionality at both molecular and physiological levels.
One of the unique selling points of the BORCS7 Gene Knockout Cell Lines is their robustness and scalability for high-throughput screening applications. Researchers benefit from the ability to conduct large-scale experiments efficiently, leading to accelerated discovery timelines. Additionally, our cell lines are rigorously validated, ensuring consistency across experiments.
For researchers, clinicians, and the biopharmaceutical industry, the value of the BORCS7 Gene Knockout Cell Lines lies in their ability to reveal fundamental insights into gene function and disease mechanisms. They represent an essential resource for driving innovations in therapeutic strategies and developing targeted interventions.
With years of expertise in genetic engineering and a commitment to advancing scientific research, our company is dedicated to providing high-quality biological products that meet the evolving needs of the research community, ensuring that your work is supported by reliable and impactful tools.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.